Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cerus Corp (CERS)

Cerus Corp (CERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 340,144
  • Shares Outstanding, K 192,172
  • Annual Sales, $ 233,800 K
  • Annual Income, $ -15,630 K
  • EBIT $ -9 M
  • EBITDA $ -7 M
  • 60-Month Beta 1.51
  • Price/Sales 1.80
  • Price/Cash Flow N/A
  • Price/Book 5.71

Options Overview Details

View History
  • Implied Volatility 464.37% (-69.02%)
  • Historical Volatility 79.80%
  • IV Percentile 98%
  • IV Rank 77.18%
  • IV High 588.50% on 04/10/25
  • IV Low 44.51% on 06/06/25
  • Expected Move (DTE 9) 0.1020 (5.70%)
  • Put/Call Vol Ratio 95.66
  • Today's Volume 3,093
  • Volume Avg (30-Day) 273
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 4,451
  • Open Int (30-Day) 4,385
  • Expected Range 1.6880 to 1.8920

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.04
  • Growth Rate Est. (year over year) +2,497,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7300 +3.47%
on 03/11/26
2.6800 -33.21%
on 03/02/26
-0.3600 (-16.74%)
since 02/11/26
3-Month
1.7300 +3.47%
on 03/11/26
2.9550 -39.42%
on 01/14/26
-0.3600 (-16.74%)
since 12/11/25
52-Week
1.1200 +59.82%
on 04/07/25
2.9550 -39.42%
on 01/14/26
+0.3000 (+20.13%)
since 03/11/25

Most Recent Stories

More News
Cathie Wood Bets $19 Million on 5 Beaten-Down Stocks

Cathie Woods’s ARK Invest deploys $19 million across five growth stocks in this uncertain market.

DKNG : 25.57 (+1.71%)
ARKF : 41.14 (-0.04%)
CMPS : 6.89 (-7.39%)
ARKW : 130.54 (+0.83%)
ARKG : 27.67 (-0.93%)
CNTN : 4.65 (-0.21%)
CERS : 1.7900 (+1.13%)
HOOD : 78.69 (+0.20%)
ARKK : 73.07 (+0.25%)
Cerus: Q4 Earnings Snapshot

Cerus: Q4 Earnings Snapshot

CERS : 1.7900 (+1.13%)
Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results

2025 Total Revenue of $233.8 million, up 16% from 2024; 2025 Product Revenue of $206.1 million, up 14% from 2024 Strengthened Financial Foundation Through Strong Commercial...

CERS : 1.7900 (+1.13%)
Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference

Cerus Corporation (Nasdaq: CERS) announced today that members of the Company’s management are scheduled to present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026, at 10:30...

CERS : 1.7900 (+1.13%)
Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026

Cerus Corporation (Nasdaq: CERS) announced today its fourth quarter and full-year 2025 financial results will be released on Monday, March 2, 2026, after the close of the stock market. The Company will...

CERS : 1.7900 (+1.13%)
DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical Practice

Cerus Corporation (Nasdaq: CERS) today announced the start of the INITIATE study by the German Red Cross Blood Donation Service Baden-Württemberg – Hessen and its subsidiary organization, the German...

CERS : 1.7900 (+1.13%)
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook

Preliminary Full-Year 2025 Product Revenue of $206.1 Million Full-Year 2026 Product Revenue Expected to be $224 Million to $228 Million, Reflecting 9%-11% Growth, Year-Over-Year...

CERS : 1.7900 (+1.13%)
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America

Cerus Corporation (Nasdaq: CERS) announced today that it has entered into a group purchasing agreement with Blood Centers of America (BCA), the largest blood supply cooperative in the U.S. BCA member blood...

CERS : 1.7900 (+1.13%)
Cerus: Q3 Earnings Snapshot

Cerus: Q3 Earnings Snapshot

CERS : 1.7900 (+1.13%)
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance

Third Quarter Total Revenue up 19% to $60.2 Million; Record Product Revenue of $52.7 Million, Up 15% Year-Over-Year Raising Full-Year 2025 Product Revenue Guidance Range...

CERS : 1.7900 (+1.13%)

Business Summary

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company...

See More

Key Turning Points

3rd Resistance Point 1.9367
2nd Resistance Point 1.8833
1st Resistance Point 1.8367
Last Price 1.7900
1st Support Level 1.7367
2nd Support Level 1.6833
3rd Support Level 1.6367

See More

52-Week High 2.9550
Fibonacci 61.8% 2.2540
Fibonacci 50% 2.0375
Fibonacci 38.2% 1.8210
Last Price 1.7900
52-Week Low 1.1200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar